Sales Growth YoY (Last 12 Months): OrganiGram (OGI)

Risks for Organigram Holdings (OGI) are driven by strict Health Canada oversight and licensing barriers. The 12-month YoY revenue growth rate on the GURU.Markets chart reflects the impact of these factors, where 39.60 captures the current value of the indicator. Cultivation patents help overcome the entry threshold, while current cyclical adaptation and cost optimization support the business's margins.
organigram.ca (OGI) - metric breakdowns and financial figures

Organigram Holdings (OGI) transition to high-tech nanoemulsion production and precision genetics should convert into a steady expansion of market presence. By analyzing the LTM sales growth YoY, an investor assesses the revenue growth rate over the last twelve months, which allows for the identification of hidden vulnerabilities in the business model and the company's ability to maintain market share during a crisis, characterizing the asset as either speculative or growth-oriented.